Volume 143, Issue 12

Search all Journal of Cancer Research and Clinical Oncology articles

December 2017

26 articles in this issue

Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate
Hirota Fujiki
Eisaburo Sueoka
Masami Suganuma
Review – Cancer Research Open access 23 September 2017 Pages: 2401 - 2412
Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma
Fei Zhang
Yun Wang
Yu-hong Li
Original Article – Cancer Research 11 August 2017 Pages: 2413 - 2424
Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients
Yueh-Hsiang Liao
Chia-Ing Li
Tsai-Chung Li
Original Article – Cancer Research 12 August 2017 Pages: 2425 - 2435
TLR9 gene polymorphism −1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population
Cecilia Martínez-Campos
Margarita Bahena-Román
Vicente Madrid-Marina
Original Article – Cancer Research 17 August 2017 Pages: 2437 - 2445
Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ
Xuan Xu
Na Li
Jie Zhang
Original Article – Cancer Research 18 August 2017 Pages: 2447 - 2453
Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection
Sen Li
Xiuwen Lan
Yingwei Xue
Original Article – Cancer Research 21 August 2017 Pages: 2455 - 2468
Modifiable health-related factors (smoking, physical activity and body mass index) and health care use and costs among adult cancer survivors
Sapna Kaul
Jaqueline C. Avila
Yong-Fang Kuo
Original Article – Cancer Research 22 August 2017 Pages: 2469 - 2480
The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese
Makiko Abe
Hidemi Ito
Keitaro Matsuo
Original Article – Cancer Research 28 August 2017 Pages: 2481 - 2492
Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer
Dongjun Jeong
Hyeongjoo Kim
Moo-Jun Baek
Original Article – Cancer Research 05 September 2017 Pages: 2493 - 2503
Prognostic role of progesterone receptor expression in a population-based analysis
Adele Caldarella
Alessandro Barchielli
Original Article – Cancer Research 09 September 2017 Pages: 2505 - 2509
Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies
Nils Winkelmann
Vivien Schäfer
Thomas Ernst
Original Article – Cancer Research 14 September 2017 Pages: 2511 - 2519
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
Maximilian Merz
Marc S. Raab
Jens Hillengass
Special Issue Manuscript 26 June 2017 Pages: 2521 - 2526
Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria
Juliane Goebel
Julia Hoischen
Kai Nassenstein
Original Article – Clinical Oncology 19 August 2017 Pages: 2527 - 2533
Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting
Ilanit Shalom-Sharabi
Ofer Lavie
Eran Ben-Arye
Original Article – Clinical Oncology 20 August 2017 Pages: 2535 - 2543
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)
Juliane Beck
Andreas Schwarzer
Wolfram Pönisch
Original Article – Clinical Oncology 21 August 2017 Pages: 2545 - 2553
Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis
Thomas Papathemelis
S. Scharl
M. Klinkhammer-Schalke
Original Article – Clinical Oncology 24 August 2017 Pages: 2555 - 2562
Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system
Jeremy Chee
Kwok Seng Loh
Chwee Ming Lim
Original Article – Clinical Oncology 28 August 2017 Pages: 2563 - 2570
Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach
Hai Huang
Qin Zhang
Wen-Hui Liu
Original Article – Clinical Oncology 28 August 2017 Pages: 2571 - 2579
Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)
Rong-xin Zhang
Jun-zhong Lin
Zhi-zhong Pan
Original Article – Clinical Oncology 28 August 2017 Pages: 2581 - 2593
Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation
A. Bauschke
A. Altendorf-Hofmann
U. Settmacher
Original Article – Clinical Oncology 28 August 2017 Pages: 2595 - 2605
Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment
Mao Lin
Shuzhen Liang
Kecheng Xu
Original Article – Clinical Oncology 04 September 2017 Pages: 2607 - 2618
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia
Qian Jiang
Haibo Wang
Robert Peter Gale
Original Article – Clinical Oncology 11 September 2017 Pages: 2619 - 2630
To block it, or not to block it?
Artur Wnorowski
Letter to the Editor Open access 27 March 2017 Pages: 2631 - 2633
Assessing risk factors of acute kidney injury after liver transplantation
Gui-Zhen Yang
Fu-Shan Xue
Hui-Xian Li
Letter to the Editor 17 August 2017 Pages: 2635 - 2636
Image-guided ablations in patients with thyroid tumors
Valerio Ferrara
Ciriaco Buonomenna
Giovanni Mauri
Letter to the Editor 02 September 2017 Pages: 2637 - 2639
Reviewer Acknowledgements 2017

Acknowledgement to Reviewers 09 November 2017 Pages: 2641 - 2643

Volume 143, Issue 12

Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate

Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma

Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients

TLR9 gene polymorphism −1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population

Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ

Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection

Modifiable health-related factors (smoking, physical activity and body mass index) and health care use and costs among adult cancer survivors

The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese

Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer

Prognostic role of progesterone receptor expression in a population-based analysis

Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies

Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma

Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria

Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)

Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis

Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system

Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach

Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)

Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation

Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment

Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia

To block it, or not to block it?

Assessing risk factors of acute kidney injury after liver transplantation

Image-guided ablations in patients with thyroid tumors

Reviewer Acknowledgements 2017

Navigation